Scientists at Lawrence Livermore National Laboratory (LLNL) announced on Monday the discovery of one of the key ways the Middle East Respiratory Syndrome Coronavirus (MERS-CoV) changes and adapts between patients, allowing for even more research on the complex condition.
MERS-CoV is a deadly disease that was first discovered in Saudi Arabia in 2012, affecting many people across the globe since. MERS-CoV is an RNA virus similar to Severe Acute Respiratory Syndrome (SARS)
The breakthrough was achieved by utilizing ultra-deep sequencing and polymerase chain reaction tests that LLNL researchers obtained from nasal samples of three camels infected with the MERS virus.
One of the more significant findings was the while only five mutations were observed in the virus’ genome sequence, approximately 500 genetic variants were identified within the samples.
Monica Borucki, an LLNL virologist and lead author of the paper where the findings were originally published, said that the discovery is an important step in understanding how the condition is able to adapt to different factors so quickly.
“There’s still an incredible amount of work to be done,” Borucki said. “MERS is something that needs to be monitored carefully. It should not be ignored.”
The ByteDance-owned TikTok faces an uphill battle in the United States after President Joe Biden…
Promising to grow space for integrating and delivering on critical defense programs by more than…
In unsealing a 13-page indictment this week, the U.S. Department of Justice (DOJ) revealed charges…
A bill targeting the illicit fentanyl supply chain, the Fentanyl Eradication and Narcotics Deterrence (FEND)…
In order to move the state closer to federal standards and allow reporting of local…
For the next round of participants in a pilot program to Accelerate the Procurement and…
This website uses cookies.